Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth ConferenceGlobeNewsWire • 07/29/21
Earnings Preview: Exagen Inc. (XGN) Q2 Earnings Expected to DeclineZacks Investment Research • 07/20/21
AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment DecisionsGlobeNewsWire • 07/13/21
Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock ConferenceGlobeNewsWire • 05/24/21
Exagen Inc. (XGN) CEO Ron Rocca on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/21
Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic TestsGlobeNewsWire • 05/04/21
Earnings Preview: Exagen Inc. (XGN) Q1 Earnings Expected to DeclineZacks Investment Research • 05/04/21
Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune DiseasesGlobeNewsWire • 03/29/21
Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 03/25/21
Exagen Inc. (XGN) CEO Ron Rocca on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/17/21
Exagen Inc. (XGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 03/09/21
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021GlobeNewsWire • 03/02/21
Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/03/21
Exagen Inc. Partners with Boston's Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune DiseasesGlobeNewsWire • 01/21/21